NANEXA Nanexa AB (publ)

STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic · nanexa.com

9.960SEK-0.30%Mkt Cap: 176.58M $P/E: —Today

Nanexa AB (publ), a pharmaceutical company, develops injectable drug products in the Nordic countries, Europe, Asia, and North America. The company offers PharmaShell, a drug delivery system based on atomic layer deposit…

Industry Peers

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

$57.06BUSD

TEVA

Teva Pharmaceutical Industries Limited Ordinary Shares

$46.10BUSDP/E 65.9

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Zoetis Inc. Class A Common Stock

$28.80BUSDP/E 11.4

UTHR

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

VTRS

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB

$14.24BUSDP/E 109.4

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated Common Stock

$11.06BUSD

RDY

Dr. Reddy's Laboratories Ltd Common Stock

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc. Class A Common Stock

$6.77BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

INDV

Indivior Pharmaceuticals, Inc. - Common Stock

$4.21BUSDP/E 12.8

Key Statistics

Company

Market Cap176.58M USD

Enterprise Value177.60M USD

Revenue (TTM)3.24M USD

Gross Profit5.35M USD

Net Income (TTM)-1.09M USD

Revenue/Share0.20 SEK

Last Price9.960 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees17

CountrySE

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)45.41

PEG—

EV/EBITDA-117.89

EV/Revenue54.84

P/S54.53

P/B14.35

EPS (TTM)-0.14

EPS (Forward)0.22

52W Range

1.40061% of range15.50

52W High15.50 SEK

52W Low1.400 SEK

Profitability

Gross Margin154.74%

Oper. Margin-839.30%

EBITDA Margin-46.52%

Profit Margin-31.50%

ROE-11.22%

ROA-8.24%

Growth

Revenue Growth-38.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-139.84K USD

CapEx (TTM)2.37M USD

FCF Margin-74.18%

FCF Yield-1.36%

Net Debt-4.95M USD

Net Debt/EBITDA3.29

Balance Sheet

Debt/Equity0.02

Current Ratio2.89

Quick Ratio2.89

Book Value/Sh0.70 SEK

Cash/Share0.28 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 SEK

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.184.79M

Float149.36M

Insiders27.24%

Institutions7.27%

Technical

SMA 505.682 (+75.3%)

SMA 2004.280 (+132.7%)

Beta1.77

S&P 52W Chg14.58%

Avg Vol (30d)2.65M

Avg Vol (10d)6.50M

Technical Indicators

RSI (14)67.0

MACD1.3762

MACD Signal0.9916

MACD Hist.+0.3845

BB Upper11.89 SEK

BB Middle7.189 SEK

BB Lower2.493 SEK

BB Width130.66%

ATR (14)1.072 SEK

Vol Ratio (20d)0.61x